These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34436052)

  • 1. SPR-Based Kinetic Analysis of the Early Stages of Infection in Cells Infected with Human Coronavirus and Treated with Hydroxychloroquine.
    Genova-Kalou P; Dyankov G; Marinov R; Mankov V; Belina E; Kisov H; Strijkova-Kenderova V; Kantardjiev T
    Biosensors (Basel); 2021 Jul; 11(8):. PubMed ID: 34436052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication.
    Cheng KW; Li S; Wang F; Ruiz-Lopez NM; Houerbi N; Chou TF
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
    Ma-Lauer Y; Zheng Y; Malešević M; von Brunn B; Fischer G; von Brunn A
    Antiviral Res; 2020 Jan; 173():104620. PubMed ID: 31634494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus.
    Łoczechin A; Séron K; Barras A; Giovanelli E; Belouzard S; Chen YT; Metzler-Nolte N; Boukherroub R; Dubuisson J; Szunerits S
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):42964-42974. PubMed ID: 31633330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three kinds of treatment with Homoharringtonine, Hydroxychloroquine or shRNA and their combination against coronavirus PEDV in vitro.
    Li CC; Wang XJ
    Virol J; 2020 Jun; 17(1):71. PubMed ID: 32493436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
    Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
    PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
    Takano T; Satoh K; Doki T; Tanabe T; Hohdatsu T
    Viruses; 2020 May; 12(5):. PubMed ID: 32456286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro.
    Pasquereau S; Nehme Z; Haidar Ahmad S; Daouad F; Van Assche J; Wallet C; Schwartz C; Rohr O; Morot-Bizot S; Herbein G
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the post-fusion core of the Human coronavirus 229E spike protein at 1.86 Å resolution.
    Yan L; Meng B; Xiang J; Wilson IA; Yang B
    Acta Crystallogr D Struct Biol; 2018 Sep; 74(Pt 9):841-851. PubMed ID: 30198895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication.
    Yan B; Chu H; Yang D; Sze KH; Lai PM; Yuan S; Shuai H; Wang Y; Kao RY; Chan JF; Yuen KY
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30654597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses.
    Kang CK; Seong MW; Choi SJ; Kim TS; Choe PG; Song SH; Kim NJ; Park WB; Oh MD
    Korean J Intern Med; 2020 Jul; 35(4):782-787. PubMed ID: 32460458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Action of Tryptanthrin Isolated from
    Tsai YC; Lee CL; Yen HR; Chang YS; Lin YP; Huang SH; Lin CW
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32120929
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
    Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
    J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effects of saikosaponins on human coronavirus 229E in vitro.
    Cheng PW; Ng LT; Chiang LC; Lin CC
    Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):612-6. PubMed ID: 16789928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
    Kara E; Demirkan K; Unal S
    Int J Antimicrob Agents; 2020 Sep; 56(3):106123. PubMed ID: 32738307
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
    Shirato K; Kanou K; Kawase M; Matsuyama S
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.